We previously reported on the efficacy of rMETase against a BRAF-V600E mutant melanoma patient-derived orthotopic xenograft (PDOX) nude mouse model and that rMETase sensitized the melanoma PDOX to temozolomide (TEM) [26]. This evidence concerns the gene BRAF and melanoma.